Trial Profile
A randomized, double-blind, multiple-dose, parallel group study to evaluate the potential withdrawal effects following administration of ELI-200 versus the reference product in methadone-maintained opioid-dependent subjects
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2015
Price :
$35
*
At a glance
- Drugs ELI 200 (Primary) ; Opioid analgesics
- Indications Pain
- Focus Therapeutic Use
- 19 Feb 2015 New trial record